A citation-based method for searching scientific literature

Irene Litvan, Jennifer G Goldman, Alexander I Tröster, Ben A Schmand, Daniel Weintraub, Ronald C Petersen, Brit Mollenhauer, Charles H Adler, Karen Marder, Caroline H Williams-Gray, Dag Aarsland, Jaime Kulisevsky, Maria C Rodriguez-Oroz, David J Burn, Roger A Barker, Murat Emre. Mov Disord 2012
Times Cited: 1420







List of co-cited articles
692 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical diagnostic criteria for dementia associated with Parkinson's disease.
Murat Emre, Dag Aarsland, Richard Brown, David J Burn, Charles Duyckaerts, Yoshikino Mizuno, Gerald Anthony Broe, Jeffrey Cummings, Dennis W Dickson, Serge Gauthier,[...]. Mov Disord 2007
34

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
23

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
Ziad S Nasreddine, Natalie A Phillips, Valérie Bédirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin, Jeffrey L Cummings, Howard Chertkow. J Am Geriatr Soc 2005
20

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
A J Hughes, S E Daniel, L Kilford, A J Lees. J Neurol Neurosurg Psychiatry 1992
18

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Claire L Tomlinson, Rebecca Stowe, Smitaa Patel, Caroline Rick, Richard Gray, Carl E Clarke. Mov Disord 2010
15

Cognitive decline in Parkinson disease.
Dag Aarsland, Byron Creese, Marios Politis, K Ray Chaudhuri, Dominic H Ffytche, Daniel Weintraub, Clive Ballard. Nat Rev Neurol 2017
455
15

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
Irene Litvan, Dag Aarsland, Charles H Adler, Jennifer G Goldman, Jaime Kulisevsky, Brit Mollenhauer, Maria C Rodriguez-Oroz, Alexander I Tröster, Daniel Weintraub. Mov Disord 2011
501
14

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.
Ian G McKeith, Bradley F Boeve, Dennis W Dickson, Glenda Halliday, John-Paul Taylor, Daniel Weintraub, Dag Aarsland, James Galvin, Johannes Attems, Clive G Ballard,[...]. Neurology 2017
14

Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis.
Angie A Kehagia, Roger A Barker, Trevor W Robbins. Neurodegener Dis 2013
288
13

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman, Glenn T Stebbins, Stanley Fahn, Pablo Martinez-Martin, Werner Poewe, Cristina Sampaio, Matthew B Stern, Richard Dodel,[...]. Mov Disord 2008
13

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.
Mariese A Hely, Wayne G J Reid, Michael A Adena, Glenda M Halliday, John G L Morris. Mov Disord 2008
13


The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.
Caroline H Williams-Gray, Jonathan R Evans, An Goris, Thomas Foltynie, Maria Ban, Trevor W Robbins, Carol Brayne, Bhaskar S Kolachana, Daniel R Weinberger, Stephen J Sawcer,[...]. Brain 2009
605
12

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.
D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, J Kulisevsky, D Burn, P Barone, J Pagonabarraga, L Allcock,[...]. Neurology 2010
482
11

Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study.
Ronald B Postuma, Alex Iranzo, Michele Hu, Birgit Högl, Bradley F Boeve, Raffaele Manni, Wolfgang H Oertel, Isabelle Arnulf, Luigi Ferini-Strambi, Monica Puligheddu,[...]. Brain 2019
360
11

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
J C Dalrymple-Alford, M R MacAskill, C T Nakas, L Livingston, C Graham, G P Crucian, T R Melzer, J Kirwan, R Keenan, S Wells,[...]. Neurology 2010
519
9

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.
C H Williams-Gray, T Foltynie, C E G Brayne, T W Robbins, R A Barker. Brain 2007
618
9

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
Caroline H Williams-Gray, Sarah L Mason, Jonathan R Evans, Thomas Foltynie, Carol Brayne, Trevor W Robbins, Roger A Barker. J Neurol Neurosurg Psychiatry 2013
357
9

Parkinsonism: onset, progression and mortality.
M M Hoehn, M D Yahr. Neurology 1967
8

Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
Jennifer G Goldman, Samantha Holden, Bryan Bernard, Bichun Ouyang, Christopher G Goetz, Glenn T Stebbins. Mov Disord 2013
85
9


Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.
Chiara Baiano, Paolo Barone, Luigi Trojano, Gabriella Santangelo. Mov Disord 2020
81
9

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.
Dag Aarsland, Kjeld Andersen, Jan P Larsen, Anette Lolk, Per Kragh-Sørensen. Arch Neurol 2003
925
8

Cognitive function in the early phase of Parkinson's disease, a five-year follow-up.
M E Domellöf, U Ekman, L Forsgren, E Elgh. Acta Neurol Scand 2015
77
10

Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Jeroen Hoogland, Judith A Boel, Rob M A de Bie, Ronald B Geskus, Ben A Schmand, John C Dalrymple-Alford, Connie Marras, Charles H Adler, Jennifer G Goldman, Alexander I Tröster,[...]. Mov Disord 2017
85
9

Reliability, validity, and clinical correlates of apathy in Parkinson's disease.
S E Starkstein, H S Mayberg, T J Preziosi, P Andrezejewski, R Leiguarda, R G Robinson. J Neuropsychiatry Clin Neurosci 1992
770
7

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.
Anette Schrag, Uzma Faisal Siddiqui, Zacharias Anastasiou, Daniel Weintraub, Jonathan M Schott. Lancet Neurol 2017
202
7

The FAB: a Frontal Assessment Battery at bedside.
B Dubois, A Slachevsky, I Litvan, B Pillon. Neurology 2000
7

Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
Kenn Freddy Pedersen, Jan Petter Larsen, Ole-Bjørn Tysnes, Guido Alves. Neurology 2017
99
7

Initial cognitive decline is associated with cortical thinning in early Parkinson disease.
Joana B Pereira, Per Svenningsson, Daniel Weintraub, Kolbjørn Brønnick, Alexander Lebedev, Eric Westman, Dag Aarsland. Neurology 2014
125
7

Defining mild cognitive impairment in Parkinson's disease.
John N Caviness, Erika Driver-Dunckley, Donald J Connor, Marwan N Sabbagh, Joseph G Hentz, Brie Noble, Virgilio Gerald H Evidente, Holly A Shill, Charles H Adler. Mov Disord 2007
313
7

Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
Eva Pirogovsky, Dawn M Schiehser, Kristalyn M Obtera, Mathes M Burke, Stephanie L Lessig, David D Song, Irene Litvan, J Vincent Filoteo. Neuropsychology 2014
58
12


Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
Roberto Monastero, Calogero Edoardo Cicero, Roberta Baschi, Marco Davì, Antonina Luca, Vincenzo Restivo, Chiara Zangara, Brigida Fierro, Mario Zappia, Alessandra Nicoletti. J Neurol 2018
61
11

Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
7

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force.
Bruno Dubois, David Burn, Christopher Goetz, Dag Aarsland, Richard G Brown, Gerald A Broe, Dennis Dickson, Charles Duyckaerts, Jefferey Cummings, Serge Gauthier,[...]. Mov Disord 2007
704
7

Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group.
J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, W Koller, C Olanow, I Shoulson. Neurology 1990
930
7


Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
Elke Kalbe, Sarah Petra Rehberg, Ines Heber, Martin Kronenbuerger, Jörg B Schulz, Alexander Storch, Katharina Linse, Christine Schneider, Susanne Gräber, Inga Liepelt-Scarfone,[...]. J Neurol Neurosurg Psychiatry 2016
57
12

Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
S Hoops, S Nazem, A D Siderowf, J E Duda, S X Xie, M B Stern, D Weintraub. Neurology 2009
653
7

Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Christopher G Goetz, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T Stebbins, Carl Counsell, Nir Giladi, Robert G Holloway, Charity G Moore, Gregor K Wenning,[...]. Mov Disord 2004
6

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson's Disease.
Blake J Lawrence, Natalie Gasson, Andrea M Loftus. Sci Rep 2016
33
18

Cognitive impairment and resting-state network connectivity in Parkinson's disease.
Hugo-Cesar Baggio, Bàrbara Segura, Roser Sala-Llonch, Maria-José Marti, Francesc Valldeoriola, Yaroslau Compta, Eduardo Tolosa, Carme Junqué. Hum Brain Mapp 2015
199
6

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
6

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Kenn Freddy Pedersen, Jan Petter Larsen, Ole-Bjorn Tysnes, Guido Alves. JAMA Neurol 2013
217
6

Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Elijah Mak, Li Su, Guy B Williams, Michael J Firbank, Rachael A Lawson, Alison J Yarnall, Gordon W Duncan, Adrian M Owen, Tien K Khoo, David J Brooks,[...]. Brain 2015
149
6

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
6

A systematic review of prevalence studies of dementia in Parkinson's disease.
Dag Aarsland, Julia Zaccai, Carol Brayne. Mov Disord 2005
537
6

Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?
Jennifer G Goldman, Samantha Holden, Bichun Ouyang, Bryan Bernard, Christopher G Goetz, Glenn T Stebbins. Mov Disord 2015
86
6

Second consensus statement on the diagnosis of multiple system atrophy.
S Gilman, G K Wenning, P A Low, D J Brooks, C J Mathias, J Q Trojanowski, N W Wood, C Colosimo, A Dürr, C J Fowler,[...]. Neurology 2008
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.